[1] |
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan.
Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 717-725.
|
[2] |
DONG Hao, QIU Yonggang, WANG Xinbin, YANG Junjie, LOU Cuncheng, YIN Lekang, YE Xiaodan.
Predictive value of logistic regression model based on high-resolution CT signs for high-grade pattern in stage ⅠA lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 768-775.
|
[3] |
LIU Xiaoli, CHAI Wenjun, SUN Lei, YAN Mingxia, PAN Hongyu, SUN Yuexi.
Analysis of differential splicing gene by regulation of splicing regulatory protein KHSRP in lung adenocarcinoma
[J]. China Oncology, 2023, 33(7): 637-645.
|
[4] |
MU Jiaqian, TENG Xiaoyan, WEI Lirong, QIU Rong, GUI Pengcheng, DU Yuzhen.
The role and application value of integrin β3 in bone metastasis of lung adenocarcinoma
[J]. China Oncology, 2022, 32(4): 351-356.
|
[5] |
ZHU Haipeng, HU Jun, JIANG Min, CAI Ruonan, WANG Junqiao, LI Li.
A study on mechanism of GOLM1 regulating PI3K/AKT/mTOR signaling pathway to promote proliferation, invasion and migration of lung adenocarcinoma cells
[J]. China Oncology, 2022, 32(3): 207-217.
|
[6] |
HOU Qinghua, ZHONG Yanfeng, LIU Linzhuang, WU Liusheng, LIU Jixian.
Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells
[J]. China Oncology, 2022, 32(2): 152-160.
|
[7] |
ZHANG Longfu, LIU Jie, NI Zheng, LU Xinyuan, HU Bin, WANG Hao, FENG Mingxiang, ZHANG Yong.
Development and validation of a nomogram for predicting spread through air spaces in stage ⅠA lung adenocarcinoma
[J]. China Oncology, 2022, 32(12): 1210-1217.
|
[8] |
HU Guannan , CHEN Lei , ZHOU Liangping , ZHOU Zhengrong .
A case report of pulmonary malignant melanoma complicated with lung adenocarcinoma and literature review
[J]. China Oncology, 2021, 31(7): 647-650.
|
[9] |
HU Yaqiong , BAI Jun , CHEN Lin , CHEN Xinlu , ZHANG Liping , ZHOU Dandan , WANG Yu , YIN Chonggao , LI Hongli , LIU Yuqing .
miR-625-5p promotes proliferation and invasion of lung adenocarcinoma by targeting PRKACA
[J]. China Oncology, 2021, 31(6): 447-454.
|
[10] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[11] |
SHI Maolin , BAI Yudi , WANG Chao , LI Siqi , ZHOU Daijun , PENG Jingjing , SUN Feifan , LI Dong , ZHANG Tao .
Effect of PD-L1 expression on the efficacy of pemetrexed-based chemotherapy in patients with advanced lung adenocarcinoma and its mechanism
[J]. China Oncology, 2021, 31(4): 308-316.
|
[12] |
WANG Xiaodong , ZHOU Dandan , ZHANG Liping , ZHENG Quan , MU Qingjie , YIN Chonggao , LI Hongli .
FAM83A is highly expressed in lung adenocarcinoma tissues and promotes invasion and metastasis of lung adenocarcinoma cells
[J]. China Oncology, 2020, 30(8): 586-592.
|
[13] |
GAO Zhiqiang,WANG Weimin,CAI Yuqing,QIN Ruoyan,GU Aiqin,XIONG Liwen,HAN Baohui,JIANG Liyan,SHI Chunlei .
Clinical efficacy of osimertinib in the treatment of 62 patients with advanced lung adenocarcinoma
[J]. China Oncology, 2019, 29(10): 809-814.
|
[14] |
WANG Shengping, FU Yi, LIU Quan, et al.
Computed tomography features of solitary pulmonary nodules in breast cancer patients: differential diagnosis between primary lung adenocarcinoma and metastatic pulmonary breast cancer
[J]. China Oncology, 2018, 28(6): 411-418.
|
[15] |
DAI Xi, LI Guoping, YANG Xiaoqiong, et al.
Effects of Lyn kinase on EGFR signaling pathway in lung adenocarcinoma
[J]. China Oncology, 2018, 28(1): 43-49.
|